The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

DSE: IBNSINA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,048	7,805	8,954	9,270	7,708	7,002
Market Cap Growth	24.88%	-12.84%	-3.40%	20.27%	10.08%	-15.15%
Enterprise Value	10,290	8,919	9,692	9,892	8,398	7,847
Last Close Price	289.60	244.69	274.85	278.97	228.05	203.91
PE Ratio	15.28	11.64	14.79	15.30	15.76	17.84
PS Ratio	0.81	0.69	0.98	1.09	1.04	1.13
PB Ratio	2.52	2.21	2.93	3.53	3.59	3.94
P/TBV Ratio	3.12	2.23	2.96	3.56	3.59	3.94
P/FCF Ratio	155.26	-	18.93	173.59	24.89	-
P/OCF Ratio	15.87	17.78	9.97	22.15	13.96	14.07
EV/Sales Ratio	0.92	0.78	1.06	1.17	1.14	1.27
EV/EBITDA Ratio	6.08	5.09	6.22	9.69	9.11	10.52
EV/EBIT Ratio	12.30	9.75	11.82	12.05	11.46	13.09
EV/FCF Ratio	176.58	-	20.49	185.25	27.12	-
Debt / Equity Ratio	0.45	0.53	0.32	0.41	0.40	0.54
Debt / EBITDA Ratio	0.97	1.06	0.62	1.02	0.91	1.25
Debt / FCF Ratio	28.28	-	2.09	20.02	2.80	-
Asset Turnover	1.86	1.98	1.96	2.08	2.03	1.98
Inventory Turnover	4.83	4.99	4.86	5.49	6.00	6.17
Quick Ratio	0.30	0.24	0.23	0.35	0.27	0.17
Current Ratio	1.15	1.13	1.26	1.46	1.26	0.83
Return on Equity (ROE)	17.34%	20.38%	21.33%	25.37%	24.91%	24.12%
Return on Assets (ROA)	8.68%	9.93%	11.00%	12.59%	12.58%	11.96%
Return on Capital (ROIC)	10.74%	12.08%	13.24%	15.30%	15.90%	15.24%
Earnings Yield	6.55%	8.59%	6.76%	6.54%	6.35%	5.61%
FCF Yield	0.64%	-2.24%	5.28%	0.58%	4.02%	-1.64%
Dividend Yield	2.18%	2.57%	2.18%	2.15%	2.06%	1.89%
Payout Ratio	30.19%	26.83%	29.49%	29.28%	26.89%	22.16%
Total Shareholder Return	2.18%	2.57%	2.18%	2.15%	2.06%	1.89%

Source: S&P Capital IQ. Standard template. Financial Sources.